(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are RALLYE, PCI BIOTECH HOLD, and SODITECH.

Financial Asset	Price	Change	Updated (EST)
RALLYE (RAL.PA)	2.10	13.61%	2023-06-21 11:02:10
PCI BIOTECH HOLD (PCIB.OL)	2.32	13.17%	2023-06-21 11:32:49
SODITECH (SEC.PA)	1.51	10.22%	2023-06-21 11:03:39
SOLSTAD OFFSHORE (SOFF.OL)	23.76	10%	2023-06-21 11:34:09
CASINO GUICHARD (CO.PA)	8.19	9.49%	2023-06-21 11:46:04
AVENIR TELECOM (AVT.PA)	0.18	9.32%	2023-06-21 11:37:39
EXPLOSIFS PROD.CHI (EXPL.PA)	106.00	9.28%	2023-06-21 11:48:55
ELECTROMAGNET GEO (EMGS.OL)	2.91	8.58%	2023-06-21 11:21:58
HDF (HDF.PA)	17.10	8.5%	2023-06-21 11:50:45
NHOA (NHOA.PA)	3.79	7.67%	2023-06-21 11:00:54

The three biggest losers today are EURASIA FONC INV, ABL Diagnostics, and BELUGA.

Financial Asset	Price	Change	Updated (EST)
EURASIA FONC INV (EFI.PA)	0.30	-17.68%	2023-06-21 08:48:23
ABL Diagnostics (ABLD.PA)	5.60	-13.85%	2023-06-21 11:35:59
BELUGA (BELU.BR)	2.50	-9.42%	2023-06-21 11:06:15
TECHNICOLOR CS (TCHCS.PA)	0.04	-9.09%	2023-06-21 11:04:16
NORDIC NANOVECTOR (NANOV.OL)	2.31	-8.33%	2023-06-21 11:31:51
PGS (PGS.OL)	5.30	-6.69%	2023-06-21 11:32:59
GENSIGHT BIOLOGICS (SIGHT.PA)	0.84	-6.67%	2023-06-21 11:50:12
DGB GROUP N.V. (DGB.AS)	0.48	-6.61%	2023-06-21 11:01:51
ALAN ALLMAN (AAA.PA)	11.00	-5.98%	2023-06-21 11:36:42
GUILLEMOT (GUI.PA)	6.96	-5.95%	2023-06-21 11:50:40

Winners today

1. RALLYE (RAL.PA)

13.61% Price Change

Rallye SA, together with its subsidiaries, engages in the food and non-food e-commerce retailing business in France and internationally. The company operates in two segments, Food and General Retailing, and Holdings and Other Activities. It operates hypermarkets, supermarkets, and convenience stores. The company conducts its retailing activities in France primarily under the Casino, Monoprix, and Franprix banners; food retail activities in Latin America mainly under the GPA food banners, Éxito, Disco-Devoto, and Libertad banners; and e-commerce comprising Cdiscount and the Cnova N.V. holding company businesses. It is also involved in the financial investment and management, property development, and energy related activities. The company was founded in 1925 and is headquartered in Paris, France. As of December 31, 2021, Rallye SA operates as a subsidiary of Foncière Euris SA.

CAC 40 ended the session with RALLYE rising 13.61% to €2.10 on Wednesday while CAC 40 slid 0.46% to €7,260.97.

Earnings Per Share

As for profitability, RALLYE has a trailing twelve months EPS of €-4.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.93%.

Volume

Today’s last reported volume for RALLYE is 650848 which is 218.65% above its average volume of 204248.

Yearly Top and Bottom Value

RALLYE’s stock is valued at €2.10 at 22:40 EST, way under its 52-week high of €3.60 and way above its 52-week low of €0.61.

Volatility

RALLYE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 9.19%, a negative 0.47%, and a positive 5.94%.

RALLYE’s highest amplitude of average volatility was 9.96% (last week), 11.36% (last month), and 5.94% (last quarter).

More news about RALLYE.

2. PCI BIOTECH HOLD (PCIB.OL)

13.17% Price Change

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PCI BIOTECH HOLD rising 13.17% to €2.32 on Wednesday while Oslo Børs Benchmark Index_GI dropped 0.53% to €1,227.58.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-0.93.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.97%.

Yearly Top and Bottom Value

PCI BIOTECH HOLD’s stock is valued at kr2.32 at 22:40 EST, way under its 52-week high of kr5.96 and way higher than its 52-week low of kr1.52.

More news about PCI BIOTECH HOLD.

3. SODITECH (SEC.PA)

10.22% Price Change

Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.

CAC 40 ended the session with SODITECH rising 10.22% to €1.51 on Wednesday, after two consecutive sessions in a row of losses. CAC 40 dropped 0.46% to €7,260.97, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, SODITECH has a trailing twelve months EPS of €0.12.

PE Ratio

SODITECH has a trailing twelve months price to earnings ratio of 12.58. Meaning, the purchaser of the share is investing €12.58 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.54%.

Moving Average

SODITECH’s worth is under its 50-day moving average of €1.56 and above its 200-day moving average of €1.49.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SODITECH’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth declined by 12.7%, now sitting on 4.59M for the twelve trailing months.

Volume

Today’s last reported volume for SODITECH is 75 which is 78.69% below its average volume of 352.

More news about SODITECH.

4. SOLSTAD OFFSHORE (SOFF.OL)

10% Price Change

Solstad Offshore ASA operates offshore service vessels and maritime services to offshore energy industry. It owns and operates platform supply vessel, anchor handling tug support vessel, and construction service vessels. The company offers subsea construction and renewable energy services, such as geotechnical work, walk to work services, grouting, SURF operations, cable laying and repair, trenching and burial, ROV support, installation of subsea equipment, survey work, IMR operations, node seismic operations, and diving and topside maintenance work. It operates a fleet of 27 construction service vessels, 20 anchor handling tug support vessels, and 39 platform supply vessels. The company was founded in 1964 and is headquartered in Skudeneshavn, Norway.

Oslo Børs Benchmark Index_GI ended the session with SOLSTAD OFFSHORE jumping 10% to €23.76 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 0.53% to €1,227.58, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, SOLSTAD OFFSHORE has a trailing twelve months EPS of kr-8.83.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.03%.

Volume

Today’s last reported volume for SOLSTAD OFFSHORE is 1320270 which is 18.84% above its average volume of 1110880.

Yearly Top and Bottom Value

SOLSTAD OFFSHORE’s stock is valued at kr23.76 at 22:40 EST, way below its 52-week high of kr52.00 and way higher than its 52-week low of kr14.28.

More news about SOLSTAD OFFSHORE.

5. CASINO GUICHARD (CO.PA)

9.49% Price Change

Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The company operates hypermarkets, supermarkets, shopping malls, and e-commerce sites, as well as convenience, discount, and cash and carry stores. It also involved in banking, digital marketing, service station, franchise, real estate asset management, property development and trading, rental, banking, and energy-related activities. It operates through stores. The company was founded in 1898 and is based in Saint-Étienne, France.

CAC 40 ended the session with CASINO GUICHARD rising 9.49% to €8.19 on Wednesday while CAC 40 slid 0.46% to €7,260.97.

Earnings Per Share

As for profitability, CASINO GUICHARD has a trailing twelve months EPS of €-2.98.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.53%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.3%, now sitting on 34B for the twelve trailing months.

Volume

Today’s last reported volume for CASINO GUICHARD is 737754 which is 14.66% above its average volume of 643405.

More news about CASINO GUICHARD.

6. AVENIR TELECOM (AVT.PA)

9.32% Price Change

Avenir Telecom S.A. designs and distributes mobile phones and mobility accessories in Europe, the Middle East, Africa, Asia, Oceania, and the Americas. The company also provides chargers, cables, memory cards, and screen protectors. It offers its products under the Energizer brand. The company was incorporated in 1989 and is headquartered in Marseille, France.

CAC 40 ended the session with AVENIR TELECOM jumping 9.32% to €0.18 on Wednesday, after three consecutive sessions in a row of losses. CAC 40 fell 0.46% to €7,260.97, after two sequential sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, AVENIR TELECOM has a trailing twelve months EPS of €161.04.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AVENIR TELECOM’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for AVENIR TELECOM is 1359670 which is 1.75% below its average volume of 1384010.

Volatility

AVENIR TELECOM’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.63%, a negative 0.30%, and a positive 4.63%.

AVENIR TELECOM’s highest amplitude of average volatility was 0.92% (last week), 2.07% (last month), and 4.63% (last quarter).

More news about AVENIR TELECOM.

7. EXPLOSIFS PROD.CHI (EXPL.PA)

9.28% Price Change

EPC Groupe engages in the manufacture, storage, and distribution of explosives in Europe, Africa, Asia Pacific, and the Americas. The company also provides drilling and mining services; logistics services; and demolition services, including mechanical demolition, deconstruction and blasting of buildings, waste management, and asbestos removal. In addition, it produces 2-ethylhexyl nitrate, a diesel fuel additive that reduces emissions and enhances diesel engine performance. It serves customers operating in the mining, cement, aggregates, civil engineering, and defense industries. EPC Groupe was founded in 1893 and is headquartered in Paris, France. EPC Groupe is a subsidiary of Ste E.J. Barbier.

CAC 40 ended the session with EXPLOSIFS PROD.CHI jumping 9.28% to €106.00 on Wednesday while CAC 40 fell 0.46% to €7,260.97.

Earnings Per Share

As for profitability, EXPLOSIFS PROD.CHI has a trailing twelve months EPS of €4.94.

PE Ratio

EXPLOSIFS PROD.CHI has a trailing twelve months price to earnings ratio of 21.46. Meaning, the purchaser of the share is investing €21.46 for every euro of annual earnings.

Volume

Today’s last reported volume for EXPLOSIFS PROD.CHI is 529 which is 179.89% above its average volume of 189.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EXPLOSIFS PROD.CHI’s stock is considered to be oversold (<=20).

More news about EXPLOSIFS PROD.CHI.

8. ELECTROMAGNET GEO (EMGS.OL)

8.58% Price Change

Electromagnetic Geoservices ASA, together with its subsidiaries, provides electromagnetic (EM) surveying services to the offshore oil and gas exploration industry. It is involved in the planning, acquisition, processing, modelling, interpretation, and integration of EM data. The company uses its patented EM survey method to find hydrocarbons in offshore reservoirs. It engages in the provision of controlled-source EM surveying and magneto telluric surveying; imaging and interpretation; rental of software and cluster; and training services. The company has operations in Europe, the Middle East, Africa, Norway, North and South America, Asia, and the Pacific Ocean. Electromagnetic Geoservices ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELECTROMAGNET GEO jumping 8.58% to €2.91 on Wednesday while Oslo Børs Benchmark Index_GI fell 0.53% to €1,227.58.

Earnings Per Share

As for profitability, ELECTROMAGNET GEO has a trailing twelve months EPS of kr0.86.

PE Ratio

ELECTROMAGNET GEO has a trailing twelve months price to earnings ratio of 3.38. Meaning, the purchaser of the share is investing kr3.38 for every norwegian krone of annual earnings.

Volatility

ELECTROMAGNET GEO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.87%, a negative 0.81%, and a positive 3.64%.

ELECTROMAGNET GEO’s highest amplitude of average volatility was 4.36% (last week), 4.71% (last month), and 3.64% (last quarter).

Volume

Today’s last reported volume for ELECTROMAGNET GEO is 3341120 which is 597.73% above its average volume of 478851.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ELECTROMAGNET GEO’s stock is considered to be oversold (<=20).

More news about ELECTROMAGNET GEO.

9. HDF (HDF.PA)

8.5% Price Change

Hydrogène de France Société anonyme develops and operates as independent power producer in France and internationally. It operates two hydrogen power plants; and manufactures and sells high power fuel cells. The company was incorporated in 2012 and is based in Lormont, France.

CAC 40 ended the session with HDF rising 8.5% to €17.10 on Wednesday while CAC 40 fell 0.46% to €7,260.97.

Earnings Per Share

As for profitability, HDF has a trailing twelve months EPS of €-0.27.

Volume

Today’s last reported volume for HDF is 5744 which is 65.53% above its average volume of 3470.

Volatility

HDF’s last week, last month’s, and last quarter’s current intraday variation average was 2.08%, 0.39%, and 2.16%.

HDF’s highest amplitude of average volatility was 7.79% (last week), 2.44% (last month), and 2.16% (last quarter).

More news about HDF.

10. NHOA (NHOA.PA)

7.67% Price Change

NHOA S.A. provides energy storage, E-mobility, and EV fastcharging infrastructure related solutions in France. The company offers solar plus storage, utility-scale storage, and industrial microgrids. It also provides charging services and devices for electric and hybrid vehicles. In addition, the company offers power house, and hybrid house; and HyESS, a technology platform for the transformation of renewables into sustainable grids, as well as Atlante, an eStation that provides fast charging solution. NHOA S.A. is based in Paris, France.

CAC 40 ended the session with NHOA jumping 7.67% to €3.79 on Wednesday while CAC 40 fell 0.46% to €7,260.97.

Earnings Per Share

As for profitability, NHOA has a trailing twelve months EPS of €-1.23.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.43%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NHOA’s stock is considered to be overbought (>=80).

Volatility

NHOA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 8.86%, a positive 0.50%, and a positive 4.18%.

NHOA’s highest amplitude of average volatility was 8.86% (last week), 5.03% (last month), and 4.18% (last quarter).

Moving Average

NHOA’s worth is way under its 50-day moving average of €4.31 and way under its 200-day moving average of €8.09.

Volume

Today’s last reported volume for NHOA is 2090 which is 89.51% below its average volume of 19930.

More news about NHOA.

Losers Today

1. EURASIA FONC INV (EFI.PA)

-17.68% Price Change

Eurasia Fonciere Investissements Société Anonyme owns, develops, and manages corporate and commercial real estate assets. The company was formerly known as MB Retail Europe and changed its name to Eurasia Fonciere Investissements Société Anonyme in January 2012. The company was founded in 1984 and is headquartered in Paris, France. Eurasia Fonciere Investissements Société Anonyme is a subsidiary of Eurasia Groupe SA.

CAC 40 ended the session with EURASIA FONC INV dropping 17.68% to €0.30 on Wednesday while CAC 40 slid 0.46% to €7,260.97.

Volume

Today’s last reported volume for EURASIA FONC INV is 3 which is 99.14% below its average volume of 351.

More news about EURASIA FONC INV.

2. ABL Diagnostics (ABLD.PA)

-13.85% Price Change

ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.

CAC 40 ended the session with ABL Diagnostics sliding 13.85% to €5.60 on Wednesday, after three successive sessions in a row of losses. CAC 40 slid 0.46% to €7,260.97, after two sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ABL Diagnostics has a trailing twelve months EPS of €-0.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.12%.

Volume

Today’s last reported volume for ABL Diagnostics is 450 which is 516.43% above its average volume of 73.

More news about ABL Diagnostics.

3. BELUGA (BELU.BR)

-9.42% Price Change

Beluga NV is a private equity and venture capital firm specializing in investments in mid venture, late venture, middle market, and mature companies. It also invests in growth capital, later stages, and buyouts. The firm invests across all sectors in companies based in Belgium with a focus on the Flanders region. It usually invests between €0.25 million ($0.37 million) and €2.5 million ($3.75 million) in the form of a minority stake in both public and private companies. The firm typically invests in companies with enterprise value between €1 million ($1.50 million) and €250 million ($375.7 million), sales values between €0.25 million ($0.37 million) and €500 million ($751.41 million), and EBITDA values between €1 million ($1.50 million) and €100 million ($150.28 million). The firm sources its capital through the stock market. Beluga NV was founded in 1998 and is based in Ternat, Belgium.

BEL 20 ended the session with BELUGA sliding 9.42% to €2.50 on Wednesday while BEL 20 slid 0.71% to €3,559.13.

Earnings Per Share

As for profitability, BELUGA has a trailing twelve months EPS of €0.02.

PE Ratio

BELUGA has a trailing twelve months price to earnings ratio of 125. Meaning, the purchaser of the share is investing €125 for every euro of annual earnings.

Volume

Today’s last reported volume for BELUGA is 1020 which is 73.58% below its average volume of 3861.

More news about BELUGA.

4. TECHNICOLOR CS (TCHCS.PA)

-9.09% Price Change

Technicolor Creative Studios provides visual effects and creative production services to the global entertainment, brand experience, film, television, animation, gaming, and advertising sectors. The company was founded in 2021 and is based in Paris, France. Technicolor Creative Studios is a former subsidiary of Technicolor SA.

CAC 40 ended the session with TECHNICOLOR CS falling 9.09% to €0.04 on Wednesday while CAC 40 fell 0.46% to €7,260.97.

Earnings Per Share

As for profitability, TECHNICOLOR CS has a trailing twelve months EPS of €-0.59.

Yearly Top and Bottom Value

TECHNICOLOR CS’s stock is valued at €0.04 at 22:40 EST, way under its 52-week low of €0.09.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TECHNICOLOR CS’s stock is considered to be overbought (>=80).

Volatility

TECHNICOLOR CS’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.76%, a negative 4.28%, and a positive 3.11%.

TECHNICOLOR CS’s highest amplitude of average volatility was 7.76% (last week), 5.30% (last month), and 3.11% (last quarter).

Moving Average

TECHNICOLOR CS’s value is way under its 50-day moving average of €0.11 and way under its 200-day moving average of €0.51.

More news about TECHNICOLOR CS.

5. NORDIC NANOVECTOR (NANOV.OL)

-8.33% Price Change

Nordic Nanovector ASA, a biopharmaceutical company, develops therapeutics for hematological cancers in Norway. The company's lead product candidate is Betalutin, a CD37-targeting radioimmunotherapy for the treatment of patients with non-hodgkin lymphoma. Its preclinical development products include Humalutin for treatment of non-Hodgkin's lymphoma; Alpha37, a CD37-targeting radioimmunotherapy for treating chronic lymphatic leukemia; and Multiple fully humanized anti-CD37 antibodies for treatment of haematological cancers and autoimmune diseases. The company is also developing 89Zr-NNV003, a CD37-targeting companion PET diagnostic for detection and dosimetry of CD37 expressing tumors. The company has collaboration agreements with Orano Med; Paul Scherrer Institute; ArevaMed; LegoChem Bio; and Heidelberg Pharma. It also has a research collaboration with the University of Pennsylvania development of a CD37-targeting CAR-T in haematological cancers. The company was formerly known as Nordic Nanovector AS and changed its name to Nordic Nanovector ASA in 2014. Nordic Nanovector ASA was incorporated in 2009 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORDIC NANOVECTOR dropping 8.33% to €2.31 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI dropped 0.53% to €1,227.58, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, NORDIC NANOVECTOR has a trailing twelve months EPS of kr-2.83.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -304.6%.

Volatility

NORDIC NANOVECTOR’s last week, last month’s, and last quarter’s current intraday variation average was 4.46%, 10.42%, and 9.11%.

NORDIC NANOVECTOR’s highest amplitude of average volatility was 7.54% (last week), 19.65% (last month), and 9.11% (last quarter).

More news about NORDIC NANOVECTOR.

6. PGS (PGS.OL)

-6.69% Price Change

PGS ASA, together with its subsidiaries, operates as a marine geophysical company primarily in Norway. The company provides a range of seismic and reservoir services, including data acquisition, imaging, interpretation, and field evaluation to oil and gas companies, as well as carbon storage and offshore wind markets. It also operates in the Asia Pacific, Canada, Egypt, the Americas, Angola, the United Kingdom, Greece, Cyprus, Ukraine, Brazil, South Africa, other African countries, the Middle East, and internationally. The company was formerly known as Petroleum Geo-Services ASA and changed its name to PGS ASA in May 2019. PGS ASA was founded in 1991 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with PGS dropping 6.69% to €5.30 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI fell 0.53% to €1,227.58, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.79%.

Yearly Top and Bottom Value

PGS’s stock is valued at kr5.30 at 22:40 EST, way under its 52-week high of kr13.15 and above its 52-week low of kr4.88.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 6.9% and 116.7%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PGS’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for PGS is 18025300 which is 13.02% above its average volume of 15948400.

More news about PGS.

7. GENSIGHT BIOLOGICS (SIGHT.PA)

-6.67% Price Change

GenSight Biologics S.A., a clinical-stage biotechnology company, discovers, develops, and commercializes therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company is also developing products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. The company was incorporated in 2012 and is headquartered in Paris, France.

CAC 40 ended the session with GENSIGHT BIOLOGICS dropping 6.67% to €0.84 on Wednesday while CAC 40 slid 0.46% to €7,260.97.

Earnings Per Share

As for profitability, GENSIGHT BIOLOGICS has a trailing twelve months EPS of €-0.72.

Volume

Today’s last reported volume for GENSIGHT BIOLOGICS is 251298 which is 45.13% below its average volume of 457998.

More news about GENSIGHT BIOLOGICS.

8. DGB GROUP N.V. (DGB.AS)

-6.61% Price Change

DGB Group N.V. invests in, develops, and manages biodiversity and carbon offset, and nature-based projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising the management and use of nature for tackling social and environmental challenges; carbon offsetting projects for reducing carbon footprint of companies; and biodiversity protection and ecosystem services. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Haarlemmermeer, the Netherlands.

AEX-Index ended the session with DGB GROUP N.V. sliding 6.61% to €0.48 on Wednesday, after three successive sessions in a row of losses. AEX-Index dropped 0.52% to €759.16, after two successive sessions in a row of losses, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -19%.

Moving Average

DGB GROUP N.V.’s value is way under its 50-day moving average of €0.63 and way below its 200-day moving average of €0.87.

More news about DGB GROUP N.V..

9. ALAN ALLMAN (AAA.PA)

-5.98% Price Change

Alan Allman Associates, together with its subsidiaries, engages in the provision of consulting services in Canada, France, Belgium, Luxembourg, Switzerland, and Singapore. The company offers technology consulting in the areas, including cybersecurity, cloud, data processing and big data, digitalization of tools and processes, etc.; strategy and management consulting comprising risk management, business intelligence, market finance, process management, change management, etc.; and industrial transformation consulting, such as purchasing and supply chain issues, relocation, cost reduction, project management, materials, and process consulting, etc. The company was incorporated in 1954 and is based in Issy-les-Moulineaux, France.

CAC 40 ended the session with ALAN ALLMAN falling 5.98% to €11.00 on Wednesday, following the last session’s upward trend. CAC 40 slid 0.46% to €7,260.97, after two sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ALAN ALLMAN has a trailing twelve months EPS of €0.22.

PE Ratio

ALAN ALLMAN has a trailing twelve months price to earnings ratio of 50. Meaning, the purchaser of the share is investing €50 for every euro of annual earnings.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 28, 2022, the estimated forward annual dividend rate is 0.05 and the estimated forward annual dividend yield is 0.51%.

Volatility

ALAN ALLMAN’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.11%, a positive 0.63%, and a positive 1.65%.

ALAN ALLMAN’s highest amplitude of average volatility was 1.19% (last week), 1.66% (last month), and 1.65% (last quarter).

Volume

Today’s last reported volume for ALAN ALLMAN is 1311 which is 77.64% above its average volume of 738.

Yearly Top and Bottom Value

ALAN ALLMAN’s stock is valued at €11.00 at 22:40 EST, way below its 52-week high of €16.10 and way above its 52-week low of €8.50.

More news about ALAN ALLMAN.

10. GUILLEMOT (GUI.PA)

-5.95% Price Change

Guillemot Corporation S.A. designs, manufactures, and sells interactive entertainment hardware and accessories in France, Germany, the United Kingdom, Spain, the United States, Canada, Italy, China, Belgium, and Romania. It offers digital hardware and peripherals under the Hercules brand name; PC and console gaming accessories under the Thrustmaster brand name; and DJ solutions for various connected devices under the DJUCED brand name. Guillemot Corporation S.A. was founded in 1984 and is based in Chantepie, France.

CAC 40 ended the session with GUILLEMOT dropping 5.95% to €6.96 on Wednesday, after two consecutive sessions in a row of gains. CAC 40 slid 0.46% to €7,260.97, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, GUILLEMOT has a trailing twelve months EPS of €1.37.

PE Ratio

GUILLEMOT has a trailing twelve months price to earnings ratio of 5.08. Meaning, the purchaser of the share is investing €5.08 for every euro of annual earnings.

More news about GUILLEMOT.

Stay up to date with our winners and losers daily report